Tissue Tek Sakura Finetek Usa Inc Torrance Ca

Lab Reagents

Human IgG antibody Laboratories manufactures the tissue tek sakura finetek usa inc torrance ca reagents distributed by Genprice. The Tissue Tek Sakura Finetek Usa Inc Torrance Ca reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact sakura tissue tek. Other Tissue products are available in stock. Specificity: Tissue Category: Tek Group: Sakura Finetek

Sakura Finetek information

TEK Rabbit pAb

A7222-100ul 100 ul
EUR 308

TEK Rabbit pAb

A7222-200ul 200 ul
EUR 459

TEK Rabbit pAb

A7222-20ul 20 ul
EUR 183

TEK Rabbit pAb

A7222-50ul 50 ul
EUR 223

TEK Conjugated Antibody

C37274 100ul
EUR 397

CA/ Rat CA ELISA Kit

ELA-E0875r 96 Tests
EUR 886

CA-5f

HY-112698 5mg
EUR 176

CA-074

HY-103350 10mg
EUR 587

AN3 CA

C0026002 One Frozen vial
EUR 543

CA 074

A1926-1 1 mg
EUR 148
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-10 10 mg
EUR 485
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-25 25 mg
EUR 746
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-5 5 mg
EUR 311
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-5.1 10 mM (in 1mL DMSO)
EUR 432
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-S Evaluation Sample
EUR 81
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA-1001

B2669-25 25mg
EUR 591

CA-1001

B2669-5 5mg
EUR 186